Discover
RDY
Dr. Reddy's Laboratories Limited
13.99
1300 x undefined
3200 x undefined
bid
ask
-
0.50
3.45%
2250 @ 04:00 PM
14.02 +0.03 (0.21%)
| Ytd | -0.36% | |
| 1y | -6.36% |
13.95
day range
14.43
12.19
52 week range
15.67
| Open | 14.34 | Prev Close | 14.49 | Low | 13.95 | High | 14.43 | Mkt Cap | 11.65B |
| Vol | 3.00M | Avg Vol | 2.59M | EPS | 0.55 | P/E | 25.44 | Forward P/E | 20.94 |
| Beta | 0.26 | Short Ratio | 14.70 | Inst. Own | 15.28% | Dividend | 0.08 | Div Yield | 0.58 |
| Ex Div Date | 07-09 | Earning | 07-22 | 50-d Avg | 13.58 | 200-d Avg | 13.86 | 1yr Est | 14.17 |
RDY News
benzinga.com
Full Transcript: Dr Reddy's Laboratories Q4 2026 Earnings Call
Dr Reddy's Laboratories (NYSE:RDY) released fourth-quarter financial results and hosted an earni
businesswire.com
Dr. Reddy's Laboratories Limited Announces Filing of Annual Report on Form 20-F
HYDERABAD, India--(BUSINESS WIRE)---- $RDY #AmericanDepositaryReceipts--Dr. Reddy's Laboratories Lim
benzinga.com
Innoviva Specialty Therapeutics Inks Agreement With Dr. Reddy's Laboratories To Develop, Commerciali
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced that